Form 8-K - Current report:
SEC Accession No. 0001437749-22-003142
Filing Date
2022-02-11
Accepted
2022-02-11 16:16:40
Documents
13
Period of Report
2022-02-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20220211_8k.htm   iXBRL 8-K 26131
  Complete submission text file 0001437749-22-003142.txt   161260

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmtp-20220211.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmtp-20220211_def.xml EX-101.DEF 11792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmtp-20220211_lab.xml EX-101.LAB 15828
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmtp-20220211_pre.xml EX-101.PRE 12007
7 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20220211_8k_htm.xml XML 2639
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 22621174
SIC: 2834 Pharmaceutical Preparations